【11.7 Live Broadcast】How to promote intelligent production with compliance data engine? Schneider Electric comes to support

In recent years, the introduction of a series of policies such as the two-invoice system, consistency evaluation of generic drugs, and quantitative procurement has brought pressure to traditional pharmaceutical companies to reduce costs and costs, forcing pharmaceutical companies to apply digital technology to improve efficiency and reduce costs
.
The epidemic since 2020 has further accelerated the process of digital transformation in the pharmaceutical industry, and more and more pharmaceutical companies are using digital empowerment as a breakthrough to improve product quality and market competitiveness, fully releasing the dividends of
digital transformation 。 As early as 2016, the "Healthy China 2030" planning outline, the document specifically mentioned the in-depth integration of new digital technologies and medical health, especially emphasizing the use of digital technology to promote the digital transformation of the medical and health industry; The Guiding Opinions of the National Medical Security Administration on Improving the "Internet +" Medical Service Prices and Medical Insurance Payment Policies issued before the epidemic clarified the reimbursement rules and standards for Internet medical services, and provided a guarantee for the circulation of drugs relying on digital technology; In March this year, nine ministries and commissions, including the Ministry of Industry and Information Technology and the National Health Commission, issued the "14th Five-Year Plan for the Development of the Pharmaceutical Industry", which clearly proposed to promote the digital transformation and upgrading of the pharmaceutical industry and improve the normalization of
the pharmaceutical supply chain.
As an important industry related to the national economy and people's livelihood, digital technology will undoubtedly bring great innovation to the pharmaceutical industry and reshape the ecology
of the entire pharmaceutical industry.
As a new production factor, data is the foundation of digitalization, networking and intelligence, and can help pharmaceutical companies reduce costs and increase efficiency by quickly integrating into pharmaceutical R&D, production, circulation, application and other links, and promote the digital upgrading
of the pharmaceutical industry.
But at the same time, the resulting data security problems also need to be paid more attention to
by pharmaceutical companies.
At present, China has successively issued the "Data Security Law" and "Personal Information Protection Law", "Network Security Review Measures", "Internet Information Service Algorithm Recommendation Management Provisions", etc.
, which have attracted the attention
of the majority of enterprises to network security and privacy protection.
Compliance management is a key mechanism and measure for enterprises to effectively prevent compliance risks and operational risks, and it is also an urgent need to ensure the healthy development of enterprises under the
new situation.
With the increasing compliance requirements for pharmaceutical enterprises in China, data compliance has gradually formed a topic in the pharmaceutical industry, but the construction situation of many enterprises is not optimistic
.
Some industry insiders said that domestic enterprises have very strong ability to collect and process data, but many enterprises, especially small enterprises, are accompanied by extensive management methods in the process of various uses of data, which has laid hidden dangers
for data compliance.
In order to help pharmaceutical companies build smart pharmaceuticals that advance both compliance and efficiency, the third phase of Schneider Electric's life science industry [Expert Materials] series of online live lectures "Promoting Intelligent Production with Compliance Data Engine" will be launched
soon 。 At 15:00 on November 7, 2022, Shen Yi, process automation architect of Schneider Electric Industrial Automation Business/Life Science Industry, will be a guest in the live broadcast room of Pharma Network, bringing you your understanding of data integrity and the explanation of digital solutions for enterprise data integrity, so stay tuned! Viewing channel: Scan the QR code below to make an appointment 【About Schneider Electric】 Schneider Electric's purpose is to empower everyone to make greater use of energy and resources, and promote human progress and sustainable common development
.
Our mission is to be your digital partner for efficiency and sustainability
.
We drive digital transformation for the home, building, data center, infrastructure and industrial markets
.
We integrate process and energy management technologies to achieve integrated enterprise management
through connected products, controls, software and services from terminal to cloud throughout the business lifecycle.
We are a global company with a local strength, committed to promoting an open technology and partner ecosystem, and actively living the shared values
of meaning, inclusion and empowerment.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice
to anyone.